342 related articles for article (PubMed ID: 870181)
1. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
Scott MT; Milas L
Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
[TBL] [Abstract][Full Text] [Related]
2. Studies using labelled C. parvum preparations in mice.
Scott MT
Dev Biol Stand; 1977 Apr 13-15; 38():123-7. PubMed ID: 608498
[TBL] [Abstract][Full Text] [Related]
3. Distribution of 3H-thymidine-labelled C. parvum in mice.
Sadler TE; Cramp WA; Castro JE
Dev Biol Stand; 1977 Apr 13-15; 38():137-43. PubMed ID: 608501
[TBL] [Abstract][Full Text] [Related]
4. The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice.
Scott MT; Warner SL
Cancer Res; 1976 Apr; 36(4):1335-8. PubMed ID: 1083289
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
Miyata H; Himeno K; Nomoto K
Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
[TBL] [Abstract][Full Text] [Related]
6. Role of inflammatory neutrophils in antitumor effects induced by intraperitoneal administration of Corynebacterium parvum in mice.
Lichtenstein AK; Berek J; Kahle J; Zighelboim J
Cancer Res; 1984 Nov; 44(11):5118-23. PubMed ID: 6488171
[TBL] [Abstract][Full Text] [Related]
7. In vitro antitumor effect of lymphoid cells from Corynebacterium parvum-treated mice: effect of route of C. parvum administration.
Ghaffar A; Cullen RT
J Natl Cancer Inst; 1977 Mar; 58(3):717-20. PubMed ID: 300113
[TBL] [Abstract][Full Text] [Related]
8. Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum.
Yuhas JM; Ullrich RL
Cancer Res; 1976 Jan; 36(1):161-6. PubMed ID: 1247995
[TBL] [Abstract][Full Text] [Related]
9. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with C. parvum.
Peters LJ; McBride WH; Mason KA; Hunter N; BasÃc I; Milas L
Dev Biol Stand; 1977 Apr 13-15; 38():297-300. PubMed ID: 608514
[TBL] [Abstract][Full Text] [Related]
10. Effect of Corynebacterium parvum on the proliferative rate of granulocyte-macrophage progenitor cells and the toxicity of chemotherapy.
Foster RS
Cancer Res; 1978 Sep; 38(9):2666-72. PubMed ID: 679169
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.
Shu SY; Chou T; Sakai K
J Immunol; 1989 Jul; 143(2):740-8. PubMed ID: 2738408
[TBL] [Abstract][Full Text] [Related]
12. Effects of Corynebacterium granulosum on weight and histology of lymphoid organs, response to mitogens, skin allografts, and a syngeneic fibrosarcoma in mice.
Milas L; Basic I; Kogelnik HD; Withers HR
Cancer Res; 1975 Sep; 35(9):2365-74. PubMed ID: 807323
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicity.
Bast RC; Knapp RC; Mitchell AK; Thurston JG; Tucker RW; Schlossman SF
J Immunol; 1979 Nov; 123(5):1945-51. PubMed ID: 489967
[TBL] [Abstract][Full Text] [Related]
14. The effect of bone marrow depletion on prostaglandin E-producing suppressor macrophages in mouse spleen.
Shibata Y; Volkman A
J Immunol; 1985 Dec; 135(6):3897-904. PubMed ID: 2933455
[TBL] [Abstract][Full Text] [Related]
15. Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells.
Chen MF; Suzuki H; Yano S
Anticancer Res; 1992; 12(2):451-6. PubMed ID: 1580562
[TBL] [Abstract][Full Text] [Related]
16. Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.
Lee KC; Berry D
J Immunol; 1977 May; 118(5):1530-40. PubMed ID: 323353
[TBL] [Abstract][Full Text] [Related]
17. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
[TBL] [Abstract][Full Text] [Related]
18. Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.
Krahenbuhl JL; Lambert LH; Remington JS
Immunology; 1976 Dec; 31(6):837-46. PubMed ID: 992714
[TBL] [Abstract][Full Text] [Related]
19. Successful immunotherapy with intraperitoneal Corynebacterium parvum in a murine ovarian cancer model is associated with the recruitment of tumor-lytic neutrophils into the peritoneal cavity.
Lichtenstein AK; Kahle J; Berek J; Zighelboim J
J Immunol; 1984 Jul; 133(1):519-26. PubMed ID: 6373934
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of Corynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma.
Pavelic ZP; Dave S; Bialkowski S; Priore RL; Greco WR
Cancer Res; 1980 Dec; 40(12):4617-21. PubMed ID: 7438095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
